1. Home
  2. AGNCM vs IRWD Comparison

AGNCM vs IRWD Comparison

Compare AGNCM & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNCM

AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

N/A

Current Price

$25.00

Market Cap

0.0

Sector

Real Estate

ML Signal

N/A

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.57

Market Cap

663.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGNCM
IRWD
Founded
2008
1998
Country
United States
United States
Employees
54
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
663.6M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
AGNCM
IRWD
Price
$25.00
$3.57
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
9.3K
2.6M
Earning Date
01-26-2026
05-11-2026
Dividend Yield
8.99%
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.24
Revenue
N/A
$298,276,000.00
Revenue This Year
$13.57
$57.95
Revenue Next Year
$63.17
$4.39
P/E Ratio
$17.72
$15.00
Revenue Growth
N/A
8.88
52 Week Low
$23.63
$0.56
52 Week High
$25.34
$5.78

Technical Indicators

Market Signals
Indicator
AGNCM
IRWD
Relative Strength Index (RSI) 57.58 41.21
Support Level $24.98 $3.07
Resistance Level $25.04 $3.92
Average True Range (ATR) 0.10 0.23
MACD -0.01 -0.04
Stochastic Oscillator 82.86 16.07

Price Performance

Historical Comparison
AGNCM
IRWD

About AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: